T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
PRHSX
Fund Status:
Open to new Retail investors  /  Open to subsequent Retail investments
Fund Composition
View the Complete Portfolio of Investments
Asset Allocation
as of 03/31/2013
Domestic Stock 83.0%
Foreign Stock 12.3%
Cash 4.9%
Convertibles 0.2%
Preferreds 0.1%
Foreign Bonds 0.0%
Options -0.5%
Volatility and Other Measures
as of 04/30/2013
Beta 0.94
R² 0.76
Standard Deviation 15.96
Price/Earnings Ratio (Domestic) 25.2
Earnings Growth Rate (Domestic) 13.6
Turnover Rate 20.9
Median Market
Capitalization 		$11,882.38 Million
10 Largest Holdings
Quarter-End Top Holdings with Weightings
Represents 29.37 % of Total Net Assets
View Holdings as of:
Alexion Pharmaceuticals
Catamaran
Cigna
Gilead Sciences
Incyte Corp
Onyx Pharmaceuticals
Pharmacyclics
Regeneron Pharmaceuticals
UnitedHealth Group
Valeant Pharmaceuticals International
As of 03/31/2013 the Health Sciences Fund had a total of 217 holdings.
Sector Diversification
as of 04/30/2013
% of Total Net Assets
Biotechnology 33.7%
Services 24.9%
Pharmaceuticals 20.7%
Products & Devices 12.5%
Life Sciences 3.8%
Miscellaneous 0.3%
See Glossary for additional details on all data elements.